311
Views
3
CrossRef citations to date
0
Altmetric
Reviews

To test, or not to test: that is the question for the future of lipoprotein(a)

, , &
Pages 241-250 | Received 18 Jan 2019, Accepted 14 Mar 2019, Published online: 03 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andreja Rehberger Likozar, Mark Zavrtanik & Miran Šebeštjen. (2020) Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options. Annals of Medicine 52:5, pages 162-177.
Read now

Articles from other publishers (2)

L.R. Ruhaak & C.M. Cobbaert. (2020) Quantifying apolipoprotein(a) in the era of proteoforms and precision medicine. Clinica Chimica Acta 511, pages 260-268.
Crossref
Natalie C. Ward, Karam M. Kostner, David R. Sullivan, Paul Nestel & Gerald F. Watts. (2019) Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far?. Journal of Clinical Medicine 8:12, pages 2073.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.